YMAB - Y-mAbs Therapeutics GAAP EPS of -$2.19 beats by $0.46 revenue of $65.27M beats by $11.88M
2023-03-30 16:39:30 ET
- Y-mAbs Therapeutics press release ( NASDAQ: YMAB ): FY GAAP EPS of -$2.19 beats by $0.46 .
- Revenue of $65.27M (+87.0% Y/Y) beats by $11.88M .
For further details see:
Y-mAbs Therapeutics GAAP EPS of -$2.19 beats by $0.46, revenue of $65.27M beats by $11.88M